Interview with Michael Schwenkert (Bio-Rad Laboratories) on best practices for the characterization and quality control of anti-idiotypic antibodies for bioanalysis

Written by Bio-Rad Laboratories
Antibodies | ADCs Drug development Interviews

We sat down with Michael Schwenkert, Technical Sales Manager for custom antibodies at Bio-Rad Laboratories, at the 9th EBF Open Meeting to find out about the work behind his poster on characterization of anti-idiotypic antibodies for high performance in bioanalytical assays. Michael described how Bio-Rad’s recombinant anti-idiotypic antibodies, made using HuCAL technology, fulfill the high quality standards demanded for use in assays to support the clinical evaluation of monoclonal antibody drugs.

Click here to view Bio-Rad’s company profile.